NASDAQ:HUGE FSD Pharma (HUGE) Stock Price, News & Analysis $0.15 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.14▼$0.1650-Day Range$0.14▼$0.3552-Week Range$0.13▼$1.68Volume1.18 million shsAverage Volume656,526 shsMarket Capitalization$5.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get FSD Pharma alerts: Email Address FSD Pharma MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.12% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.63Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.22) to ($0.12) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.97 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for FSD Pharma.Read more about FSD Pharma's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.12% of the float of FSD Pharma has been sold short.Short Interest Ratio / Days to CoverFSD Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in FSD Pharma has recently decreased by 56.95%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldFSD Pharma does not currently pay a dividend.Dividend GrowthFSD Pharma does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HUGE. Previous Next 2.6 News and Social Media Coverage News SentimentFSD Pharma has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for FSD Pharma this week, compared to 1 article on an average week.Search Interest1 people have searched for HUGE on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, FSD Pharma insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.53% of the stock of FSD Pharma is held by insiders.Percentage Held by InstitutionsOnly 1.24% of the stock of FSD Pharma is held by institutions.Read more about FSD Pharma's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for FSD Pharma are expected to grow in the coming year, from ($0.22) to ($0.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of FSD Pharma is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of FSD Pharma is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFSD Pharma has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about FSD Pharma's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About FSD Pharma Stock (NASDAQ:HUGE)FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.Read More HUGE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HUGE Stock News HeadlinesJuly 24 at 5:19 AM | msn.comRobotaxis, FSD, AI: These are a few of Elon Musk’s favorite Tesla thingsMay 28, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd in Acute Alcohol IntoxicationJuly 27, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.May 28, 2024 | finance.yahoo.comFSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol IntoxicationMay 27, 2024 | yahoo.comStorms collapse roof, other damage at Lake CumberlandMay 27, 2024 | msn.comThe Checkup: ‘Junk patents’ by big pharma lead to soaring drugs prices, FTC saysMay 20, 2024 | investorplace.comHUGE Stock Earnings: FSD Pharma Reported Results for Q1 2024May 16, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzdJuly 27, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.April 29, 2024 | msn.comNeural Networks And AI's Rapid Progression Ignite A Multi-Trillion-Dollar Economic ShiftApril 29, 2024 | seekingalpha.comWall Street Breakfast: Self-Driving PushApril 29, 2024 | thestreet.comTesla shares soar as Elon Musk returns from China with FSD 'Game Changer'April 29, 2024 | msn.comApple, Amazon, Fed Rates Could Have a Devastating Effect on Stocks, Here’s Why. And 5 Other Things to Know Before Markets Open.April 23, 2024 | finance.yahoo.comUS to provide 'significant' new security assistance for Ukraine, Biden tells ZelenskiyApril 23, 2024 | news.yahoo.comI’m a doctor in Haiti. Crisis may be death sentence for many with health problems | OpinionApril 22, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzdApril 18, 2024 | msn.comSaudi Arabia Earns Top Marks in Global AI Index for National StrategyApril 18, 2024 | seekingalpha.comTesla Stock: Plunging Toward My Price TargetSee More Headlines Receive HUGE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FSD Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:HUGE CUSIPN/A CIK1771885 Webfsdpharma.com Phone(416) 854-8884FaxN/AEmployees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,900,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-74.06% Return on Assets-55.31% Debt Debt-to-Equity RatioN/A Current Ratio2.34 Quick Ratio2.34 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.33 per share Price / Book0.44Miscellaneous Outstanding Shares40,120,000Free Float36,695,000Market Cap$5.83 million OptionableOptionable Beta0.60 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Zeeshan Saeed (Age 54)Founder, CEO, President & Executive Co-Chairman Comp: $222.62kMr. Anthony John Durkacz (Age 48)Founder & Executive Co-Chairman Comp: $222.62kMr. Nathan Coyle CPA (Age 43)Chief Financial Officer Comp: $178.21kMr. Donal Carroll CPA (Age 47)Chief Operating Officer Comp: $225.62kDr. Lakshmi P. Kotra BPHARM (Age 53)Ph.D., CEO of Lucid & Director Comp: $144.72kMs. Maryann AdessoCorporate SecretaryRandell MackPresident of FSD BioSciencesDr. Andrzej Chruscinski M.D.Ph.D., Vice President of Clinical & Scientific Affairs of LucidMr. Kevin CassidyVice President of Quality-LucidMore ExecutivesKey CompetitorsMEI PharmaNASDAQ:MEIPCocrystal PharmaNASDAQ:COCPBioVieNASDAQ:BIVIMinerva NeurosciencesNASDAQ:NERVHCW BiologicsNASDAQ:HCWBView All Competitors HUGE Stock Analysis - Frequently Asked Questions How have HUGE shares performed this year? FSD Pharma's stock was trading at $0.9198 at the beginning of 2024. Since then, HUGE stock has decreased by 84.2% and is now trading at $0.1454. View the best growth stocks for 2024 here. How were FSD Pharma's earnings last quarter? FSD Pharma Inc. (NASDAQ:HUGE) posted its earnings results on Tuesday, May, 14th. The company reported ($0.05) EPS for the quarter, hitting the consensus estimate of ($0.05). How do I buy shares of FSD Pharma? Shares of HUGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of FSD Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Aurora Cannabis (ACB), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA), Assertio (ASRT), Bionano Genomics (BNGO), Ideanomics (IDEX) and Stealth BioTherapeutics (MITO). This page (NASDAQ:HUGE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HUGE Stock Alerts